U.S. Nuclear Regulatory Commission.
Notice of meeting.
The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of fluorine-18 and therapeutic radiopharmaceuticals as medical events; and the training and experience requirements for the medical use of NeoVista, Inc.'s Epi-Rad90 strontium-90 ophthalmic system. A copy of the agenda for the meeting will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by contacting Ms. Ashley Tull using the information below.
The teleconference meeting will be held on Thursday, December 18, 2008, from 1 p.m. to 3 p.m. Eastern Standard Time.
Public Participation: Any member of the public who wishes to participate in the teleconference discussion should contact Ms. Tull using the contact information below.
Contact Information: Ashley M. Tull, e-mail: email@example.com, telephone: (240) 888-7129.
Conduct of the Meeting
Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Tull at the contact information listed above. All submittals must be received by December 15, 2008, and must pertain to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman.
3. The transcript will be available on the ACMUI's Web site (http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about January 21, 2009. A meeting summary will be available on or about February 3, 2009.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of Federal Regulations, Part 7.Start Signature
Dated: December 1, 2008.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E8-28843 Filed 12-4-08; 8:45 am]
BILLING CODE 7590-01-P